
    
      We will give 50mg of dasatinib daily since the diagnosis for up to 6 months, for the first
      2-4 weeks we will evaluate hematic biometry to registry hematic response, at months 3 and 6 a
      BCR/ABL PCR will be taken to evaluate molecular response.
    
  